Subject‐driven titration of biphasic insulin aspart 30 twice daily is non‐inferior to investigator‐driven titration in Chinese patients with type 2 diabetes inadequately controlled with premixed human insulin: A randomized, open‐label, parallel‐group, multicenter trial

AIMS/INTRODUCTION: The present study was to compare the efficacy and safety of subject‐driven and investigator‐driven titration of biphasic insulin aspart 30 (BIAsp 30) twice daily (BID). MATERIALS AND METHODS: In this 20‐week, randomized, open‐label, two‐group parallel, multicenter trial, Chinese p...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Wenying, Zhu, Lvyun, Meng, Bangzhu, Liu, Yu, Wang, Wenhui, Ye, Shandong, Sun, Li, Miao, Heng, Guo, Lian, Wang, Zhanjian, Lv, Xiaofeng, Li, Quanmin, Ji, Qiuhe, Zhao, Weigang, Yang, Gangyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718111/
https://www.ncbi.nlm.nih.gov/pubmed/26816605
http://dx.doi.org/10.1111/jdi.12364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718111/
https://www.ncbi.nlm.nih.gov/pubmed/26816605
http://dx.doi.org/10.1111/jdi.12364

Ejemplares similares